To validate the inhibition of NASH advancement due to the actions of CSP, SSa, and NGN (as shown in Supporting Information 2, SSa and NGN have been proven to be active components of CSP), we employed PPC as a reference for comparison. Here, DNAJC5 is linked to metabolic dysfunction-associated steatohepatitis.